| 缩写名/全名 |
CELL CHEM BIOL
Cell Chemical Biology |
||||||||||||||||||||||||||||||||||||
| ISSN号 | 2451-9448 | ||||||||||||||||||||||||||||||||||||
| 研究方向 | - | ||||||||||||||||||||||||||||||||||||
| 影响因子 | 2015:0, 2016:0, 2017:5.592, 2018:6.762, 2019:7.739, | ||||||||||||||||||||||||||||||||||||
| 出版国家 | |||||||||||||||||||||||||||||||||||||
| 出版周期 | |||||||||||||||||||||||||||||||||||||
| 年文章数 | 151 | ||||||||||||||||||||||||||||||||||||
| 出版年份 | 0 | ||||||||||||||||||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||||||||||||||||||
| 审稿周期(仅供参考) | |||||||||||||||||||||||||||||||||||||
| 录用比例 | |||||||||||||||||||||||||||||||||||||
| 投稿链接 | https://www.editorialmanager.com/cell/default.aspx | ||||||||||||||||||||||||||||||||||||
| 投稿官网 | https://www.cell.com/ | ||||||||||||||||||||||||||||||||||||
| h-index | 166 | ||||||||||||||||||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2451-9448%5BISSN%5D | ||||||||||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Protease-Mediated Protein Quality Control for Bacterial Acid Resistance. Author: He D1, Zhang M2, Liu S1, Xie X1, Chen PR3. Journal: Cell Chem Biol. 2019 Jan 17;26(1):144-150.e3. doi: 10.1016/j.chembiol.2018.10.014. Epub 2018 Nov 21. PubMed DOI |
| 2. | HTiP: High-Throughput Immunomodulator Phenotypic Screening Platform to Reveal IAP Antagonists as Anti-cancer Immune Enhancers. Author: Mo X1, Tang C2, Niu Q1, Ma T1, Du Y1, Fu H3. Journal: Cell Chem Biol. 2019 Mar 21;26(3):331-339.e3. doi: 10.1016/j.chembiol.2018.11.011. Epub 2019 Jan 10. PubMed DOI |
| 3. | Discovery of Small-Molecule Inhibitors of the HSP90-Calcineurin-NFAT Pathway against Glioblastoma. Author: Liu Z1, Li H2, He L3, Xiang Y4, Tian C5, Li C3, Tan P3, Jing J3, Tian Y6, Du L7, Huang Y3, Han L8, Li M9, Zhou Y10. Journal: Cell Chem Biol. 2019 Mar 21;26(3):352-365.e7. doi: 10.1016/j.chembiol.2018.11.009. Epub 2019 Jan 10. PubMed DOI |
| 4. | Frenolicin B Targets Peroxiredoxin 1 and Glutaredoxin 3 to Trigger ROS/4E-BP1-Mediated Antitumor Effects. Author: Ye Q1, Zhang Y2, Cao Y1, Wang X2, Guo Y1, Chen J3, Horn J4, Ponomareva LV4, Chaiswing L5, Shaaban KA4, Wei Q5, Anderson BD6, St Clair DK5, Zhu H3, Leggas M6, Thorson JS7, She QB8. Journal: Cell Chem Biol. 2019 Mar 21;26(3):366-377.e12. doi: 10.1016/j.chembiol.2018.11.013. Epub 2019 Jan 17. PubMed DOI |
| 5. | Investigation of Penicillin Binding Protein (PBP)-like Peptide Cyclase and Hydrolase in Surugamide Non-ribosomal Peptide Biosynthesis. Author: Zhou Y1, Lin X2, Xu C3, Shen Y1, Wang SP1, Liao H1, Li L1, Deng H4, Lin HW5. Journal: Cell Chem Biol. 2019 May 16;26(5):737-744.e4. doi: 10.1016/j.chembiol.2019.02.010. Epub 2019 Mar 21. PubMed DOI |
| 6. | Small Molecules with Big Promises for Curing Demyelinating Diseases. Author: Han F1, Zhou MM2. Journal: Cell Chem Biol. 2019 Apr 18;26(4):468-470. doi: 10.1016/j.chembiol.2019.04.006. PubMed DOI |
| 7. | Parvifoline AA Promotes Susceptibility of Hepatocarcinoma to Natural Killer Cell-Mediated Cytolysis by Targeting Peroxiredoxin. Author: Zhu H1, Wang B1, Kong L2, An T2, Li G2, Zhou H2, Gong L1, Zhao Z1, Gong Y2, Sun H2, Puno P3, Li Y4. Journal: Cell Chem Biol. 2019 Apr 16. pii: S2451-9456(19)30117-5. doi: 10.1016/j.chembiol.2019.04.003. [Epub ahead of print] PubMed DOI |
|
|
